Cognitive Impairment in Patients With Breast Cancer: Understanding the Impact of Chemotherapy and Endocrine Therapy

J Clin Oncol. 2020 Jun 10;38(17):1871-1874. doi: 10.1200/JCO.20.00336. Epub 2020 Mar 6.

Authors

Patricia A Ganz^{1

2}, Kathleen Van Dyk^{1

3}

Affiliations

¹ University of California Los Angeles Jonsson Comprehensive Cancer Center, and David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA.
² University of California Los Angeles, Fielding School of Public Health, Los Angeles, CA.
³ University of California Los Angeles, Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Breast Neoplasms* / drug therapy
Chemotherapy, Adjuvant
Cognitive Dysfunction* / chemically induced
Female
Humans
Immunologic Factors / therapeutic use
Patient Reported Outcome Measures

Substances

Immunologic Factors

Grants and funding